Shiqun Chen Selected Research

Shiqun Chen Research Topics

Disease

22	Coronary Artery Disease (Coronary Atherosclerosis) 12/2024 - 01/2021
18	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 01/2013
13	Heart Failure 09/2023 - 01/2016
12	Diabetes Mellitus 10/2023 - 01/2016
11	Myocardial Infarction 03/2024 - 04/2019
10	Chronic Renal Insufficiency 01/2023 - 01/2020
8	Malnutrition (Nutritional Deficiencies) 02/2022 - 01/2021
6	Inflammation (Inflammations) 03/2024 - 04/2019
6	ST Elevation Myocardial Infarction 01/2022 - 11/2017
5	Atrial Fibrillation 01/2022 - 01/2021
5	Hypertension (High Blood Pressure) 01/2022 - 01/2017
4	Cardiovascular Diseases (Cardiovascular Disease) 09/2023 - 11/2019
4	Anemia 01/2022 - 01/2016
3	Acute Coronary Syndrome 10/2023 - 11/2017
3	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2022
3	Mitral Valve Insufficiency (Mitral Regurgitation) 09/2023 - 01/2022
3	Renal Insufficiency (Renal Failure) 10/2020 - 01/2016
3	Hyperuricemia 06/2020 - 01/2013
2	Hyperglycemia 10/2023 - 09/2022
2	Neoplasms (Cancer) 01/2023 - 05/2020
1	Atherosclerosis 03/2024
1	Atherosclerotic Plaque (Atheroma) 03/2024
1	Kidney Calculi (Kidney Stone) 11/2023
1	Insulin Resistance 11/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Diabetes Complications 01/2022
1	Hypoalbuminemia 12/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Stroke (Strokes) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 05/2020
1	Drug-Related Side Effects and Adverse Reactions 04/2019

Drug/Important Bio-Agent (IBA)

8	CreatinineIBA 12/2024 - 01/2013
7	LDL CholesterolIBA 01/2022 - 01/2021
7	oxidized low density lipoproteinIBA 01/2022 - 01/2021
6	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2022
5	HDL CholesterolIBA 03/2024 - 01/2018
4	AlbuminsIBA 10/2023 - 12/2021
3	Uric Acid (Urate)IBA 01/2023 - 01/2013
3	C-Reactive ProteinIBA 01/2022 - 01/2018
3	Lipoprotein(a)IBA 01/2021 - 01/2021
3	DiureticsIBA 07/2019 - 01/2013
2	Cystatin CIBA 12/2024 - 11/2022
2	omega-Chloroacetophenone (Mace)IBA 09/2023 - 01/2022
2	Hemoglobins (Hemoglobin)IBA 01/2023 - 12/2021
2	Triglycerides (Triacylglycerol)IBA 11/2022 - 01/2021
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2022 - 01/2021
2	CholesterolIBA 02/2022 - 04/2021
2	Sodium-Glucose Transport ProteinsIBA 01/2022 - 01/2021
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2021
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2021
2	LipidsIBA 01/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 08/2019 - 04/2019
2	Contrast MediaIBA 08/2019 - 01/2019
1	Fibrinogen (Factor I)FDA Link 03/2024
1	HDL LipoproteinsIBA 03/2024
1	Calcium OxalateIBA 11/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2023
1	Blood Glucose (Blood Sugar)IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 11/2022
1	SodiumIBA 01/2022
1	SymportersIBA 01/2022
1	BilirubinIBA 01/2022
1	Apolipoproteins B (ApoB)IBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	MB Form Creatine KinaseIBA 01/2021
1	Acetylcysteine (Siran)FDA LinkGeneric 10/2020
1	SilverIBA 05/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Glycerophospholipids (Phosphoglycerides)IBA 04/2019
1	iopromide (Ultravist)FDA Link 04/2019
1	Saline SolutionIBA 01/2016

Therapy/Procedure

30	Percutaneous Coronary Intervention 10/2023 - 01/2013
3	Therapeutics 01/2022 - 01/2013
1	Renal Dialysis (Hemodialysis) 10/2020
1	Stents 01/2016